 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Nephros: Q3 Earnings Insights

SOUTH ORANGE, NJ, Nov. 01, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial...

Nephros Hires Judy Krandel as Chief Financial Officer

SOUTH ORANGE, NJ, Oct. 25, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial...

Nephros Schedules Third Quarter 2023 Financial Results Conference Call

South Orange, New Jersey--(Newsfile Corp. - September 19, 2023) - Nephros, Inc. (NASDAQ: NEPH), a leading water technology company providing filtration solutions to the medical and commercial...

Nephros to Present at LD Micro Main Event XVI

Nephros (NASDAQ:NEPH Get Free Report) and NanoString Technologies (NASDAQ:NSTG Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their valuation, profitability, risk, institutional ownership, analyst...

Nephros (NASDAQ:NEPH) vs. NanoString Technologies (NASDAQ:NSTG) Head to Head Survey

Nephros, Inc. (NEPH) Q2 2023 Earnings Call Transcript

Nephros GAAP EPS of -$0.04 beats by $0.02, revenue of $3.5M beats by $0.4M

Second-Quarter Net Revenue of $3.5 Million, a 24% Increase Over 2022;Year-to-Date Revenue Increases 45%; Maintains Positive Cash Flow Results SOUTH ORANGE, NJ, Aug. 09, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration ...

Nephros Announces Results for Quarter Ended June 30, 2023

Nephros (NASDAQ:NEPH  Get Free Report) and Minerva Surgical (NASDAQ:UTRS  Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their profitability, institutional ownership, analyst ...

Nephros (NASDAQ:NEPH) & Minerva Surgical (NASDAQ:UTRS) Financial Contrast

SOUTH ORANGE, NJ, July 26, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced that it will file its second-quarter financial results on Wednesday, August 9, ...

Nephros Schedules Second Quarter 2023 Financial Results Conference Call

Nephros, Inc. is a medical device company, which engages in developing and selling liquid purification filters and an on-line mid dilution hemodiafiltration system. The company operates in two segments: Water Filtration, Pathogen Detection and Renal Products. The Water Filtration segment includes both the medical device and commercial filtration product lines. The Pathogen Detection segment develops and sells portable, real-time water testing systems designed to provide actionable data on waterborne pathogens in approximately one hour. The Renal Products segment consists of SRP, which is focused on the development of medical device products for patients with renal disease, including a second-generation HDF system for the treatment of patients with ESRD. Its ultrafilters are used in dialysis centers for the removal of biological contaminants from water, bicarbonate concentrate, and blood. The company was founded on April 3, 1997 and is headquartered in South Orange, NJ.

Watchers	270
52-Wk Low	$0.95
52-Wk High	$2.50

Market Cap	$24.01M
Volume (M)	4,826.00
52-Wk High	$2.50
52-Wk Low	$0.95

NEPH Nephros Inc

About

Feed

News

Earnings

Fundamentals